MARATTO

article · Journal of the Pakistan Medical Association

Evaluation of left ventricular function after sofosbuvir and daclatasvir regimen for chronic hepatitis C

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Sofosbuvir-daclatasvir combination therapy did not affect or impair left ventricular systolic or diastolic functions.

Research topics

  • Hepatitis C virus research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.47391/jpma.egy-s4-27

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.